Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Photocure ASA

Market Cap 160.44Cr 17Cr 15Cr 13Cr 13Cr 24Cr 1.59TCr 24Cr 158.6Cr 62Cr 781.51Cr 63Cr 62Cr 2.7TCr P/E 2026 *
17.5x
P/E 2027 * 35.8x
Enterprise Value 136.24Cr 14Cr 12Cr 11Cr 11Cr 20Cr 1.35TCr 20Cr 134.67Cr 52Cr 663.63Cr 54Cr 53Cr 2.3TCr EV / Sales 2026 *
2.07x
EV / Sales 2027 * 2.02x
Free-Float
94.52%
Yield 2026 *
-
Yield 2027 * -
1 day-0.64%
Current month-16.37%
1 month-16.37%
3 months-12.59%
6 months+10.75%
Current year-11.71%
1 month 6.18
Extreme 6.18
6.73
Current year 6.18
Extreme 6.18
7.39
1 year 5.15
Extreme 5.15
7.39
3 years 4.32
Extreme 4.32
7.39
5 years 4.21
Extreme 4.21
15.87
10 years 3
Extreme 3
17.57
Manager TitleAgeSince
Chief Executive Officer - 01/11/2018
Chief Executive Officer - 01/07/2018
Chief Tech/Sci/R&D Officer - 01/08/2021
Director TitleAgeSince
Director/Board Member - 01/01/2022
Chairman - 27/09/2023
Director/Board Member - 23/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
-0.64%0.00% - - 17Cr
-0.94%-2.14%+40.54%+148.38% 1,00100Cr
-0.42%-1.80%+53.69%+42.60% 57TCr
-0.56%-1.65%+19.27%+59.57% 39TCr
-1.18%+0.68%+24.66%+16.53% 33TCr
+1.09%+1.65%+26.61%+33.32% 28TCr
+1.42%-1.17%+24.53%+14.29% 28TCr
+1.87%+0.87%-41.49%-48.26% 19TCr
-1.78%+1.16%+17.79%+48.77% 19TCr
-1.40%+3.27%+16.16%+59.08% 16TCr
Average -0.25%+0.70%+20.20%+41.59% 37.52TCr
Weighted average by Cap. -0.38%-0.36%+29.20%+66.27%

Financials

2026 *2027 *
Net sales 66Cr 6.92Cr 5.97Cr 5.49Cr 5.17Cr 9.71Cr 653.08Cr 9.79Cr 65Cr 25Cr 320.52Cr 26Cr 25Cr 1.11TCr 66Cr 6.97Cr 6.02Cr 5.53Cr 5.21Cr 9.78Cr 658.04Cr 9.86Cr 66Cr 26Cr 322.95Cr 26Cr 26Cr 1.12TCr
Net income 9.23Cr 97.11L 83.77L 77.02L 72.49L 1.36Cr 92Cr 1.37Cr 9.13Cr 3.55Cr 45Cr 3.64Cr 3.57Cr 155.59Cr 4.5Cr 47.33L 40.83L 37.54L 35.33L 66.39L 45Cr 66.95L 4.45Cr 1.73Cr 22Cr 1.78Cr 1.74Cr 76Cr
Net Debt -24Cr -2.55Cr -2.2Cr -2.02Cr -1.9Cr -3.57Cr -240.19Cr -3.6Cr -24Cr -9.31Cr -117.88Cr -9.55Cr -9.35Cr -407.8Cr -26Cr -2.76Cr -2.38Cr -2.19Cr -2.06Cr -3.88Cr -260.7Cr -3.91Cr -26Cr -10Cr -127.95Cr -10Cr -10Cr -442.63Cr
Logo Photocure ASA
Photocure ASA is a Norway-based company active in the pharmaceutical industry. The Company is focused on developing and improving photodynamic technology and owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. Based on the Photocure Technology platform, Photocure has developed and commercialized Hexvix (Hyperthermic IntraVEsical Chemotherapy) and Cysview (hexaminolevulinate HCL) for use in bladder cancer. The Company’s activities are divided into two business segments: The Commercial Franchise and The Development Portfolio. The Commercial Franchise segment includes Hexvix/Cysview by geography (U.S. and Europe) and other sales (partners and other products including sales revenues for Hivec). The Development Portfolio segment includes development of pipeline products.
Employees
100
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
60.30NOK
Average target price
84.00NOK
Spread / Average Target
+39.30%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!